CLINICAL_TRIALS
research
· 2025-07-11
Clinical Trial Update: Adult Spinal Muscular Atrophy (SMA) China Registry
Summary
Biogen-sponsored adult spinal muscular atrophy registry in China (NCT05618379) is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Biogen | Conditions: Muscular Atrophy, Spinal | Status: ACTIVE_NOT_RECRUITING